Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

NUVB

+ Watchlist+ Portfolio

Nuvation Bio Inc. Class A

Regulated industryPhysical productsSells to businessesDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$3.90
52-Week Range
$3.77 – $9.75
Market Cap
$1.33B
P/E (TTM)
—
EPS (TTM)
-0.39
Dividend Yield
0.00%
Advanced Metrics
Price/Book
5.85
PEG Ratio
—
Return on Equity
-49.09%
Return on Assets
-11.18%
Gross Margin
85.79%
Operating Margin
-61.17%
Profit Margin
-67.38%
Current Ratio
7.45
Debt/Equity
2.05
Total Debt
$468.12M
Free Cash Flow
$-76.06M
Revenue Growth
242.60%
Earnings Growth
—
Enterprise Value
$1.14B

Market Snapshot

About

Nuvation Bio Inc. is a clinical-stage biopharmaceutical company developing precision oncology therapies. The company focuses on cancer treatments targeting specific genetic alterations and tumor biology mechanisms.